PI Industries - To See Healthy Double-Digit Growth In CSM Business Aided By New Product Launches: Dolat Capital

[ad_1]

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

PI Industries Ltd.’s FY22 annual report speaks vividly on the company ’s focus towards strengthening and expanding its custom synthesis and manufacturing offerings driven by strong research and development and technical capabilities, diversification of CSM portfolio into non-agrochem applications, expansion of its horticulture offerings under ‘JIVAGRO’ brand and accelerated efforts towards introduction of new molecules in the domestic market.

PI Industries’ CSM business continued its strong growth trajectory registering growth of 20.1% YoY (on a higher base of FY21) to Rs 39.9 billion.

With a strong pipeline of more than 40 products at different stages of development, surge in enquiries from existing as well as potential clients, addition of new capacities (two multi-purpose plants), foray into specialised area of electronic chemicals and a robust order book of ~ $1.4 billion, CSM business should continue to deliver 20% plus growth in FY23 and beyond .

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.



[ad_2]

Image and article originally from www.bqprime.com. Read the original article here.